drugset / Trial / NCT00936871
The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects
RandomizedCrossoverSingle-blindTreatment
Summary
This study has been designed to investigate the effect of lersivirine on the QT/QTc interval in order to help establish the safety profile of lersivirine.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lersivirine | Small molecule | 2100 mg | Oral |
| Subject | Lersivirine | Small molecule | 2400 mg | Oral |
| Subject | Moxifloxacin | Small molecule | 400 mg | — |
Indications
No indication recorded.